Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in Acta Neuropathol

Retrieve available abstracts of 73 articles:
HTML format
Text format



Single Articles


    May 2018
  1. VON BUEREN AO, Karremann M, Gielen GH, Benesch M, et al
    A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".
    Acta Neuropathol. 2018 May 21. pii: 10.1007/s00401-018-1863.
    PubMed     Text format    


  2. LESKE H, Rushing E, Budka H, Niehusmann P, et al
    K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution.
    Acta Neuropathol. 2018 May 15. pii: 10.1007/s00401-018-1867.
    PubMed     Text format    


    April 2018
  3. SHIRAHATA M, Ono T, Stichel D, Schrimpf D, et al
    Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
    Acta Neuropathol. 2018 Apr 23. pii: 10.1007/s00401-018-1849.
    PubMed     Text format     Abstract available


  4. PHI JH, Park AK, Lee S, Choi SA, et al
    Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
    Acta Neuropathol. 2018 Apr 11. pii: 10.1007/s00401-018-1845.
    PubMed     Text format     Abstract available


  5. KATZ LM, Hielscher T, Liechty B, Silverman J, et al
    Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
    Acta Neuropathol. 2018 Apr 7. pii: 10.1007/s00401-018-1844.
    PubMed     Text format     Abstract available


  6. BARTHEL FP, Wesseling P, Verhaak RGW
    Reconstructing the molecular life history of gliomas.
    Acta Neuropathol. 2018 Apr 3. pii: 10.1007/s00401-018-1842.
    PubMed     Text format     Abstract available


    March 2018
  7. KORSHUNOV A, Sahm F, Stichel D, Schrimpf D, et al
    Molecular characterization of medulloblastomas with extensive nodularity (MBEN).
    Acta Neuropathol. 2018 Mar 22. pii: 10.1007/s00401-018-1840.
    PubMed     Text format     Abstract available


  8. REINHARDT A, Stichel D, Schrimpf D, Sahm F, et al
    Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Acta Neuropathol. 2018 Mar 21. pii: 10.1007/s00401-018-1837.
    PubMed     Text format     Abstract available


  9. NEIDERT MC, Kowalewski DJ, Silginer M, Kapolou K, et al
    The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy.
    Acta Neuropathol. 2018 Mar 20. pii: 10.1007/s00401-018-1836.
    PubMed     Text format     Abstract available


  10. APPS JR, Carreno G, Gonzalez-Meljem JM, Haston S, et al
    Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
    Acta Neuropathol. 2018 Mar 14. pii: 10.1007/s00401-018-1830.
    PubMed     Text format     Abstract available


  11. LOUIS DN, Giannini C, Capper D, Paulus W, et al
    cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.
    Acta Neuropathol. 2018 Mar 1. pii: 10.1007/s00401-018-1826.
    PubMed     Text format    


    February 2018
  12. LABRECHE K, Kinnersley B, Berzero G, Di Stefano AL, et al
    Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci.
    Acta Neuropathol. 2018 Feb 19. pii: 10.1007/s00401-018-1825.
    PubMed     Text format     Abstract available


  13. IORGULESCU JB, Van Ziffle J, Stevers M, Grenert JP, et al
    Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.
    Acta Neuropathol. 2018 Feb 12. pii: 10.1007/s00401-018-1819.
    PubMed     Text format    


  14. GLOWACKA WK, Jain H, Okura M, Maimaitiming A, et al
    5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.
    Acta Neuropathol. 2018 Feb 10. pii: 10.1007/s00401-018-1821.
    PubMed     Text format     Abstract available


    January 2018
  15. BADY P, Kurscheid S, Delorenzi M, Gorlia T, et al
    The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
    Acta Neuropathol. 2018 Jan 24. pii: 10.1007/s00401-018-1810.
    PubMed     Text format     Abstract available


  16. MUSTAFA DAM, Pedrosa RMSM, Smid M, van der Weiden M, et al
    T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.
    Acta Neuropathol. 2018 Jan 19. pii: 10.1007/s00401-018-1806.
    PubMed     Text format     Abstract available


  17. PRATT D, Natarajan SK, Banda A, Giannini C, et al
    Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.
    Acta Neuropathol. 2018 Jan 4. pii: 10.1007/s00401-018-1805.
    PubMed     Text format    


    November 2017
  18. BOGEAS A, Morvan-Dubois G, El-Habr EA, Lejeune FX, et al
    Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
    Acta Neuropathol. 2017 Nov 17. doi: 10.1007/s00401-017-1783.
    PubMed     Text format     Abstract available


  19. HASSELBLATT M, Johann PD, Kool M, Fruhwald MC, et al
    Reduced histone H3 K27 trimethylation is encountered in about 50% of atypical teratoid/rhabdoid tumors (AT/RT) but is not associated with molecular subgroup status and outcome.
    Acta Neuropathol. 2017;134:817-818.
    PubMed     Text format    


  20. PANWALKAR P, Clark J, Ramaswamy V, Hawes D, et al
    Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.
    Acta Neuropathol. 2017;134:705-714.
    PubMed     Text format     Abstract available


    October 2017
  21. LOPEZ GY, Oberheim Bush NA, Phillips JJ, Bouffard JP, et al
    Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.
    Acta Neuropathol. 2017 Oct 23. doi: 10.1007/s00401-017-1780.
    PubMed     Text format    


  22. WIJNENGA MMJ, Dubbink HJ, French PJ, Synhaeve NE, et al
    Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification.
    Acta Neuropathol. 2017 Oct 19. doi: 10.1007/s00401-017-1781.
    PubMed     Text format    


  23. BEYER U, Brand F, Martens H, Weder J, et al
    Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.
    Acta Neuropathol. 2017 Oct 13. doi: 10.1007/s00401-017-1774.
    PubMed     Text format     Abstract available


  24. KORSHUNOV A, Chavez L, Northcott PA, Sharma T, et al
    DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma.
    Acta Neuropathol. 2017 Oct 13. doi: 10.1007/s00401-017-1776.
    PubMed     Text format    


    August 2017
  25. NOMURA M, Mukasa A, Nagae G, Yamamoto S, et al
    Distinct molecular profile of diffuse cerebellar gliomas.
    Acta Neuropathol. 2017 Aug 29. doi: 10.1007/s00401-017-1771.
    PubMed     Text format     Abstract available


  26. D'ARONCO L, Rouleau C, Gayden T, Crevier L, et al
    Brainstem angiocentric gliomas with MYB-QKI rearrangements.
    Acta Neuropathol. 2017 Aug 12. doi: 10.1007/s00401-017-1763.
    PubMed     Text format    


  27. LOUIS DN, von Deimling A
    Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zulch, the WHO... and Shakespeare.
    Acta Neuropathol. 2017 Aug 11. doi: 10.1007/s00401-017-1765.
    PubMed     Text format    


  28. CHAN E, Bollen AW, Sirohi D, Van Ziffle J, et al
    Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex.
    Acta Neuropathol. 2017 Aug 3. doi: 10.1007/s00401-017-1759.
    PubMed     Text format    


  29. SINGH M, Venugopal C, Tokar T, Brown KR, et al
    RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
    Acta Neuropathol. 2017 Aug 1. doi: 10.1007/s00401-017-1757.
    PubMed     Text format     Abstract available


    July 2017
  30. NEUMANN JE, Swartling FJ, Schuller U
    Medulloblastoma: experimental models and reality.
    Acta Neuropathol. 2017 Jul 19. doi: 10.1007/s00401-017-1753.
    PubMed     Text format     Abstract available


    June 2017
  31. EUSKIRCHEN P, Bielle F, Labreche K, Kloosterman WP, et al
    Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.
    Acta Neuropathol. 2017 Jun 21. doi: 10.1007/s00401-017-1743.
    PubMed     Text format     Abstract available


    May 2017
  32. SAHM F, Toprak UH, Hubschmann D, Kleinheinz K, et al
    Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature.
    Acta Neuropathol. 2017 May 4. doi: 10.1007/s00401-017-1715.
    PubMed     Text format    


    April 2017
  33. KORSHUNOV A, Schrimpf D, Ryzhova M, Sturm D, et al
    H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers.
    Acta Neuropathol. 2017 Apr 11. doi: 10.1007/s00401-017-1710.
    PubMed     Text format     Abstract available


  34. PUSCH S, Krausert S, Fischer V, Balss J, et al
    Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.
    Acta Neuropathol. 2017;133:629-644.
    PubMed     Text format     Abstract available


    March 2017
  35. RAPP C, Warta R, Stamova S, Nowrouzi A, et al
    Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens.
    Acta Neuropathol. 2017 Mar 22. doi: 10.1007/s00401-017-1702.
    PubMed     Text format     Abstract available


  36. PEKMEZCI M, Rice T, Molinaro AM, Walsh KM, et al
    Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
    Acta Neuropathol. 2017 Mar 2. doi: 10.1007/s00401-017-1690.
    PubMed     Text format     Abstract available


  37. FUKUSHIMA S, Yamashita S, Kobayashi H, Takami H, et al
    Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas.
    Acta Neuropathol. 2017;133:445-462.
    PubMed     Text format     Abstract available


  38. HUSE JT, Snuderl M, Jones DT, Brathwaite CD, et al
    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway.
    Acta Neuropathol. 2017;133:417-429.
    PubMed     Text format     Abstract available


    January 2017
  39. OLAR A, Wani KM, Wilson CD, Zadeh G, et al
    Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
    Acta Neuropathol. 2017 Jan 27. doi: 10.1007/s00401-017-1678.
    PubMed     Text format     Abstract available


  40. LENTING K, Verhaak R, Ter Laan M, Wesseling P, et al
    Glioma: experimental models and reality.
    Acta Neuropathol. 2017 Jan 10. doi: 10.1007/s00401-017-1671.
    PubMed     Text format     Abstract available


  41. PAJTLER KW, Mack SC, Ramaswamy V, Smith CA, et al
    The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.
    Acta Neuropathol. 2017;133:5-12.
    PubMed     Text format     Abstract available


  42. LOUIS DN, Aldape K, Brat DJ, Capper D, et al
    Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.
    Acta Neuropathol. 2017;133:1-3.
    PubMed     Text format    


    December 2016
  43. EL-HABR EA, Dubois LG, Burel-Vandenbos F, Bogeas A, et al
    A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma.
    Acta Neuropathol. 2016 Dec 28. doi: 10.1007/s00401-016-1659.
    PubMed     Text format     Abstract available


    August 2016
  44. TABOURET E, Nguyen AT, Dehais C, Carpentier C, et al
    Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
    Acta Neuropathol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  45. BAUMGARTEN P, Gessler F, Schittenhelm J, Skardelly M, et al
    Brain invasion in otherwise benign meningiomas does not predict tumor recurrence.
    Acta Neuropathol. 2016.
    PubMed     Text format    


    May 2016
  46. FERRIS SP, Goode B, Joseph NM, Kline CN, et al
    IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
    Acta Neuropathol. 2016.
    PubMed     Text format    


  47. CASTEL D, Grill J, Debily MA
    Histone H3 genotyping refines clinico-radiological diagnostic and prognostic criteria in DIPG.
    Acta Neuropathol. 2016;131:795-6.
    PubMed     Text format    


    April 2016
  48. RAMASWAMY V, Remke M, Bouffet E, Bailey S, et al
    Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
    Acta Neuropathol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  49. JANSEN MH, Veldhuijzen van Zanten SE, Heymans MW, Hargrave D, et al
    Commentary on "Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes".
    Acta Neuropathol. 2016.
    PubMed     Text format    


    January 2016
  50. BRONISCER A, Chamdine O, Hwang S, Lin T, et al
    Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas.
    Acta Neuropathol. 2016.
    PubMed     Text format     Abstract available


  51. HERRLINGER U, Jones DT, Glas M, Hattingen E, et al
    Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Acta Neuropathol. 2016.
    PubMed     Text format    


    December 2015
  52. BRANDENBURG S, Muller A, Turkowski K, Radev YT, et al
    Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  53. SAHM F, Schrimpf D, Jones DT, Meyer J, et al
    Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  54. HERRLINGER U, Jones DT, Glas M, Hattingen E, et al
    Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  55. CASTEL D, Philippe C, Calmon R, Le Dret L, et al
    Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  56. LIU Q, Liu Y, Li W, Wang X, et al
    Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  57. HO CY, Mobley BC, Gordish-Dressman H, VandenBussche CJ, et al
    A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  58. GESSI M, Gielen GH, Dreschmann V, Waha A, et al
    High frequency of H3F3A mutations characterizes pediatric and adult high-grade gliomas of the spinal cord.
    Acta Neuropathol. 2015.
    PubMed     Text format    


    July 2015
  59. MENKE JR, Raleigh DR, Gown AM, Thomas S, et al
    Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen.
    Acta Neuropathol. 2015.
    PubMed     Text format    


    June 2015
  60. LIVERMAN C, Mafra M, Chuang SS, Shivane A, et al
    A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern.
    Acta Neuropathol. 2015.
    PubMed     Text format    


  61. OHLI J, Neumann JE, Grammel D, Schuller U, et al
    Localization of SHH medulloblastoma in mice depends on the age at its initiation.
    Acta Neuropathol. 2015.
    PubMed     Text format    


  62. ICHIMURA K, Narita Y, Hawkins CE
    Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.
    Acta Neuropathol. 2015;129:789-808.
    PubMed     Text format     Abstract available


  63. REUSS DE, Mamatjan Y, Schrimpf D, Capper D, et al
    IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
    Acta Neuropathol. 2015;129:867-73.
    PubMed     Text format     Abstract available


  64. WESSELING P, van den Bent M, Perry A
    Oligodendroglioma: pathology, molecular mechanisms and markers.
    Acta Neuropathol. 2015;129:809-27.
    PubMed     Text format     Abstract available


  65. THOMAS C, Ruland V, Kordes U, Hartung S, et al
    Pediatric atypical choroid plexus papilloma reconsidered: increased mitotic activity is prognostic only in older children.
    Acta Neuropathol. 2015;129:925-7.
    PubMed     Text format    


  66. DE LA FOUCHARDIERE A, Cabaret O, Petre J, Aydin S, et al
    Primary leptomeningeal melanoma is part of the BAP1-related cancer syndrome.
    Acta Neuropathol. 2015;129:921-3.
    PubMed     Text format    


  67. COLLINS VP, Jones DT, Giannini C
    Pilocytic astrocytoma: pathology, molecular mechanisms and markers.
    Acta Neuropathol. 2015;129:775-88.
    PubMed     Text format     Abstract available


    May 2015
  68. PAULUS W
    Pathology, molecular mechanisms and markers of gliomas: new insight and new challenges.
    Acta Neuropathol. 2015.
    PubMed     Text format    


    April 2015
  69. RODRIGUEZ FJ, Schniederjan MJ, Nicolaides T, Tihan T, et al
    High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN).
    Acta Neuropathol. 2015;129:609-10.
    PubMed     Text format    


    January 2015
  70. SAHM F, von Deimling A
    Farewell to oligoastrocytoma: response to letters.
    Acta Neuropathol. 2015;129:155.
    PubMed     Text format    


  71. WILCOX P, Li CC, Lee M, Shivalingam B, et al
    Oligoastrocytomas: throwing the baby out with the bathwater?
    Acta Neuropathol. 2015;129:147-9.
    PubMed     Text format    


    October 2014
  72. SAHM F, Reuss D, Koelsche C, Capper D, et al
    Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
    Acta Neuropathol. 2014;128:551-9.
    PubMed     Text format     Abstract available


  73. DE KOCK L, Sabbaghian N, Druker H, Weber E, et al
    Germ-line and somatic DICER1 mutations in pineoblastoma.
    Acta Neuropathol. 2014;128:583-95.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: